CV Lattes
ResearcherID
ORCID
Google Scholar Citations
Universidade de São Paulo (USP). Faculdade de Medicina de Ribeirão Preto (FMRP) (Institutional affiliation from the last research proposal) Birthplace: Brazil
Professor Alline Campos has a Bachelor's degree in Pharmacy from the Federal University of Juiz de Fora (2005), an M.Sc and Ph.D. in Pharmacology from the University of São Paulo (2006-2011), with a sandwich period at the Complutense University of Madrid (Spain - 2009-2010 ). Postdoctoral fellow in the Department of Infectious Diseases and Tropical Medicine at the Federal University of Minas Gerais (2011-2013) and the Department of Molecular Biology and Neuronal Signaling at the Max-Planck Institute for Experimental Medicine in the city of Gottingen-Germany (2014- 2015). Boehringer Ingelheim Fonds short-term visits program in Prof. Dr. Gerd Kempermann's lab at the Center for Regenerative Therapies in Dresden-Germany. Joined the Department of Pharmacology at the Faculty of Medicine of Ribeirão Preto -USP, where she leads the Pharmacology laboratory of (Neuro) plasticity. Her research group studied the molecular and biochemical aspects of NEURO-REGENERATION in the context of neuropsychopharmacology. Her group seeks to understand how our daily experiences, environmental factors (such as stress), changes in the intestinal microbiota, and some inflammatory and infectious diseases can negatively modulate neuroplasticity. In her lab, they use experimental in vitro, in vivo, and translational approaches to find new targets for treating anxiety disorders, major depression, autism spectrum disorder, and neurodegenerative disorders, such as Alzheimer's. An Advocate of diversity and in the promotion of Women in Science projects, in 2015 she was one of the laureates of For Women of Science award (L'oreal-UNESCO-ABC). She is also one of the founders of the project aiming scientific dissemination of the science made by women, Vírginias da Ciência (www.virginiasdaciencia.com.br) (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Testosterone is the main pharmacological approach used by transmasculine individuals during gender-affirming hormone therapy (GAHT-T). Although presenting a safe profile, it can increase cardiovascular risk in this population. Of note, the literature lacks studies addressing the effects of testosterone, and related mechanisms, in the cardiovascular system of biological female organisms, e…
The first one thousand days of life are essential and, at the same time, a critical and vulnerable period for brain development. During the embryonic period, our central nervous system, neurons, microglia and astrocytes are formed and given their specific (but still basic) designations related to location (anatomical and histological), neurotransmitters (release and expressed receptors) e…
Cannabidiol (CBD) is a non-psychotomimetic phytocannabinoid derived from Cannabis sativa. It has possible therapeutic effects over a broad range of neuropsychiatric disorders. Although the mechanisms of these effects are still far from clear, they may involve its neuroprotective properties and different receptors. Of note, the dose range related to CBD effects may vary from species, anim…
The SARS-CoV-2 pandemic is causing the saturation of health systems worldwide mainly due to the severity of some respiratory symptoms induced by the course of the disease in some patients. However, the report of patients about the occurrence of anosmia in course of pathology has opened questions about the participation of a neural and, perhaps neurodegenerative, component of SARS-COV-2-in…
(Only some records are available in English at this moment)
Current hypotheses relate neurodevelopmental disorders to alterations in neuroplastic processes in the development and structuring of neural circuitry. Additionally, genetic factors and variations in the timing of exposure to inflammatory environments during the pre- and postnatal periods may explain the differences between disorders. Among the known neurodevelopmental disorders, Autism S…
Approximately one-third of COVID-19 patients may develop psychiatric and neurological problems up to six months after infection, a phenomenon known as Long COVID. These symptoms include cognitive issues, memory loss, tingling sensations, dizziness, sensitivity to light and noise, and autonomic dysfunction, regardless of the severity of the respiratory illness. Exosomes, nanosized biovesic…
Cells of the innate immune system can acquire "memory" via epigenetic reprogramming after stimuli with microbial ligands. This functional readjustment allows inflammatory responses to be enhanced in secondary challenges, a process called "trained innate immunity". On the other hand, these cells could also develop immunological tolerance depending on the concentration of the ligand and the…
(Only some records are available in English at this moment)
As the incidence of new Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infections has decreased, the World Health Organization has declared the SARS-CoV-2 pandemic to be over. However, the impact of this viral outbreak may last longer with the occurrence of neurological and psychiatric symptoms in those infected with SARS-CoV-2 several months after the display of primary res…
Cannabidiol (CBD) is currently one of the most studied drug in the field of neuropsychopharmacology, due to its enormous potential for therapeutic uses. We have recently demonstrated, using preclinical approaches and 4 case-reports, that CBD can be used as add-on drug to potentiate and reduce latency for the late-onset of therapeutic effects of the antidepressant and escitalopram. Our res…
The medial prefrontal cortex (mPFC) participates in the neurobiology of stress responses and in the pathophysiology of anxiety- and depression-like phenotypes. The activity of GABAergic interneurons modulates mPFC function and controls the behavioral responses coordinated by this brain region. Interestingly, reactive glial cells, particularly NG2 glial cells, are a potential source of new…
| 2 / 2 | Ongoing grants |
| 4 / 4 | Completed research grants |
| 1 / 1 | Ongoing scholarships in Brazil |
| 8 / 6 | Completed scholarships in Brazil |
| 1 / 1 | Ongoing scholarships abroad |
| 2 / 2 | Completed scholarships abroad |
| 18 / 16 | All research grants and scholarships |
| Associated processes | |